Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 5/20 | 0.72 |
| ▸ | HTT | P42858 | 1/20 | 0.72 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.72 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.72 |
| ▸ | POLB | P06746 | 2/20 | 0.62 |
| ▸ | ELANE | P08246 | 2/20 | 0.62 |
| ▸ | MEN1 | O00255 | 2/20 | 0.55 |
| ▸ | MAPT | P10636 | 2/20 | 0.55 |
| ▸ | ATM | Q13315 | 1/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.53 |
| ▸ | HPGD | P15428 | 3/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | GLA | P06280 | 2/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | ENPP3 | O14638 | 1/20 | 0.47 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.47 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10291941 | 0.98 | KMT2A (0.75) | KMT2AHTTSMN1; SMN2TDP1POLB | |
| SCHEMBL26038796 | 0.95 | KMT2A (0.66) | KMT2AHTTSMN1; SMN2TDP1POLB | |
| SCHEMBL8319948 | 0.95 | KMT2A (0.81) | KMT2AHTTSMN1; SMN2TDP1POLB | |
| Cyclohexane Carboxamide SCHEMBL21771917 | 0.92 | KMT2A (0.62) | KMT2AHTTSMN1; SMN2TDP1POLB | |
| SCHEMBL24605352 | 0.91 | KMT2A (0.68) | KMT2AHTTSMN1; SMN2TDP1POLB | |
| SCHEMBL12370833 | 0.91 | KMT2A (0.68) | KMT2AHTTSMN1; SMN2TDP1POLB | |
| SCHEMBL27947111 | 0.91 | KMT2A (0.68) | KMT2AHTTSMN1; SMN2TDP1POLB | |
| SCHEMBL2741099 | 0.91 | KMT2A (0.68) | KMT2AHTTSMN1; SMN2TDP1POLB | |
| SCHEMBL10574401 | 0.91 | KMT2A (0.88) | KMT2AHTTSMN1; SMN2TDP1POLB | |
| SCHEMBL21185911 | 0.86 | HTT (0.61) | KMT2AHTTSMN1; SMN2TDP1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9500790-B2 | Optical film, circularly polarizing plate, and image display device | Konica Minolta, Inc. (JP) | 2016-11-22 | — | — | US | disclosed |
| US-9309463-B2 | Liquid crystal compound, liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2016-04-12 | — | — | US | disclosed |
| US-20150247963-A1 | OPTICAL FILM, CIRCULARLY POLARIZING PLATE, AND IMAGE DISPLAY DEVICE | Konica Minolta, Inc. (JP) | 2015-09-03 | — | — | US | disclosed |
| US-8956552-B2 | Cyclohexene-3,6-diyl compound, liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2015-02-17 | — | — | US | disclosed |
| US-8846164-B2 | Compound having propyl ether as bonding group, liquid crystal composition thereof and liquid crystal display device thereof | JNC CORPORATION (JP) | 2014-09-30 | — | — | US | disclosed |
| US-20140077131-A1 | LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC PETROCHEMICAL CORPORATION (JP) | 2014-03-20 | — | — | US | disclosed |
| CN-103562198-A | Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity | CHIESI FARMA SPA | 2014-02-05 | — | — | CN | disclosed |
| US-20130277612-A1 | CYCLOHEXENE-3,6-DIYL COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC PETROCHEMICAL CORPORATION | 2013-10-24 | — | — | US | disclosed |
| US-20130126783-A1 | COMPOUND HAVING PROPYL ETHER AS BONDING GROUP, LIQUID CRYSTAL COMPOSITION THEREOF AND LIQUID CRYSTAL DISPLAY DEVICE THEREOF | JNC PETROCHEMICAL CORPORATION (JP) | 2013-05-23 | — | — | US | disclosed |
| US-20120168677-A1 | LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC PETROCHEMICAL CORPORATION (JP) | 2012-07-05 | — | — | US | disclosed |
| CN-100448824-C | Decahydronaphthalene derivatives | DAINIPPON INK & CHEMICALS (JP) | 2009-01-07 | — | — | CN | disclosed |
| EP-1013177-B1 | A game-type flavouring agent. | NESTLE SA (CH) | 2003-09-03 | — | — | EP | disclosed |
| US-6592924-B2 | Combination of an alkylphenol and cyclohexanecarboxylic acid or an alkyl-substituted derivative | NESTEC S.A. (CH) | 2003-07-15 | — | — | US | disclosed |
| CN-1321141-A | Decahydronaphthalene derivatives | DAINIPPON INK & CHEMICALS (JP) | 2001-11-07 | — | — | CN | disclosed |
| EP-1013177-A1 | A game-type flavouring agent. | SOCIETE DES PRODUITS NESTLE S.A. (CH) | 2000-06-28 | — | — | EP | disclosed |
| CN-1140194-A | Liquid crystalline compound having branched alkyl group at its side chain and liquid crystal composition containing the same | CHISSO CORP (JP) | 1997-01-15 | — | — | CN | disclosed |
| US-4098817-A | OXIDATION OF CYCLOALIPHATIC COMPOUNDS | PETRO-TEX CHEMICAL CORPORATION (US) | 1978-07-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120168677-A1 | LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | CXCR1, OCIAD1, LEO1 | KMT2A 2912/4885HTT 3148/4885SMN1; SMN2 4683/4885 |
| US-20150247963-A1 | OPTICAL FILM, CIRCULARLY POLARIZING PLATE, AND IMAGE DISPLAY DEVICE | SUN2, HTR3D, CRY1 | KMT2A 907/4885HTT 1189/4885SMN1; SMN2 1468/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.